Abstract
Rationale
The THEME method for measuring time-determined patterns (T-patterns) in behavior has been suggested as a new, more objective method for assessing cognitive disturbances in schizophrenia.
Objectives
THEME was used to compare responses of schizophrenic patients with those having mood, schizoaffective, or severe anxiety disorders, and with healthy control subjects.
Methods
A two-choice, button-pressing task was used to elicit T-patterns among responses, with knowledge-of-results (K) rewards and coin reinforcements (RF) as reinforcers. Subjects were compared by diagnosis, drug treatment, and gender.
Results
Schizophrenic and manic patients showed excessive numbers of, and more complex T-patterns than controls. Schizophrenic and manic patients frequently demonstrated repetitive (stereotyped) responding, an effect never seen in healthy controls. Although clozapine (CLZ) reduced both excessive T-pattern structure and stereotyped responding, it also reduced growth of responding to the coin RF.
Conclusions
Significant T-pattern increases may represent a common, time-related symptom of schizophrenia and mania. CLZ’s effect on T-pattern production suggests that receptor effects other than the DAD2 antagonism of “typical” neuroleptics’ may be relevant to these findings.
Similar content being viewed by others
References
American Psychiatric Association (1987) DSM-III-R: Diagnostic and statistical manual of mental disorders, 3rd edn., revised. APA, Washington
American Psychiatric Association (1998) DSM-IV TR: Diagnostic and statistical manual of mental disorders, 4th edn., revised. APA, Washington
Anonymous (1999) SAS/STAT user’s guide, version 8. SAS Institute, Inc., Gary, NC
Baldwin AE, Sadeghian K, Kelley AE (2002) Appetitive instrumental learning requires coincident activation of NMDA and dopamine D1 receptors within the medial prefrontal cortex. J Neurosci 22:1063–1071
Berrettini WH (2000) Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol Psychiatry 48:531–538
Bleuler E (1910/1950) Dementia praecox. International University Press, New York
Carlsson A (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1:179–186
Carlsson A (1995) Neurocircuitries and neurotransmitter interactions in schizophrenia. Int Clin Psychopharmacol 3[Suppl 10]:21–28
Carlsson A (2001) A paradigm shift in brain research. Science 294:1021–1024
Carlsson M, Carlsson A (1989) Marked locomotor stimulation in monoamine-depleted mice following treatment with atropine in combination with clonidine. J Neurotransm 1:317–322
Chen L, Yang CR (2002) Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex. J Neurophysiol 87:2324–2336
Cobb WS, Abercrombie ED (2002) Distinct roles for nigral GABA and glutamate receptors in the regulation of dendritic dopamine release under normal conditions and in response to systemic haloperidol. J Neurosci 22:1407–1413
Cooper SJ, Dourish CT (1990) Neurobiology of stereotyped behavior. Clarendon Press, Oxford
Ellenbroek B, Willemen A, Cools A (1989) Are antagonists of dopamine D1 receptors drugs that attenuate both positive and negative symptoms of schizophrenia? A pilot study in Java monkeys. Neuropsychopharmacology 2:191–199
Fenu S, Bassareo V, Di Chiara G (2001) A role for dopamine D1 receptors of the nucleus accumbens shell in conditioned taste aversion learning. J Neurosci 21:6897–6904
Friedman JI, Temporini H, Davis KL (1999) Pharmacologic strategies for augmenting cognitive performance in schizophrenia. Biol Psychiatry 45:1–16
Frith CD, Done DJ (1983) Stereotyped responding by schizophrenic patients on a two-choice guessing task. Psychol Med 13:779–786
Gerlach J, Peacock L (1995) New antipsychotics: the present status. Int Clin Psychopharmacol 10[Suppl 3]:39–48
Grube BS, Bilder RM, Goldman RS (1998) Meta-analysis of symptom factors in schizophrenia. Schizophr Res 31:113–120
Guidotti A, Auta J, Davis JM, Gerevini VD, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold D, Sharma R, Uzunov D, Costa E (2000) Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder. Arch Gen Psychiatry 57:1061–1069
Joel D, Avisar A, Doljansky J (2001) Enhancement of excessive lever-pressing after post-training signal attenuation in rats by repeated administration of the D1 antagonist SCH 23390 or the D2 agonist quinpirole, but not the D1 agonist SKF 38393 or the D2 antagonist haloperidol. Behav Neurosci 115:1291–1300
Kapur S, Remington G (2001) Dopamine D2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biol Psychiatry 50:873–883
Keefe RSE, Mohs RC, Bilder RM, Harvey PD, Green MF, Meltzer HY, Gold JM, Sano M (2003) Neurocognitive assessment in the clinical antipsychotic trials of intervention effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. Schizophr Bull 29:45–55
Kelso JAS (1997) Dynamic patterns: the self-organization of brain and behavior. MIT Press, Cambridge
Kerns JM, Sierens DK, Kao LC, Klawans HL, Carvey PM (1992) Synaptic plasticity in the rat striatum following chronic haloperidol treatment. Clin Neuropharmacol 15:488–500
Konradi C, Heckers S (2001) Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Biol Psychiatry 50:729–742
Kreipke CW, Walker PD (2002) NMDA antagonism and D1-receptor stimulation synergistically induces c-Fos within the striatum and produces hyperlocomotor, stereotypical, and hypersensitive behavior. Program No. 165.11, Society for Neuroscience, Washington, DC
LaHoste GJ, Henry BL, Marshall JF (2000) Dopamine D1 receptors synergize with D2, but not D3 or D4, receptors in the striatum without the involvement of action potentials. J Neurosci 20:6666–6671
Laruelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R (1999) Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 46:56–72
Lyon M, Robbins TW (1975) The action of central nervous system stimulant drugs: a general theory concerning amphetamine effects. In: Essman W, Valzelli L (eds) Current developments in psychopharmacology, 2nd edn. Spectrum Publications, Inc., New York, pp 79–163
Lyon M, Lyon N, Magnusson MS (1994) The importance of temporal structure in analyzing schizophrenic behavior: some theoretical and diagnostic implications. Schizophr Res 13:45–56
Lyon N, Gerlach J (1988) Perseverative structuring of responses by schizophrenic and affective disorder patients. J Psychiatry Res 21:261–277
Magnusson MS (1996) Hidden real-time patterns in intra- and inter-individual behavior: description and detection. Eur J Psychol Assess 12:112–123
Magnusson MS (2000) Discovering hidden time patterns in behavior: T-patterns and their detection. Behav Res Meth Instrum Comput 12:93–110
Overall J, Gorham D (1962) The brief psychiatric rating scale. Psychol Reports 10:799–812
Paulus MP, Braff DL (2003) Chaos and schizophrenia: does the method fit the madness? Biol Psychiatry 53:3–11
Peacock L, Gerlach J (1999) New and old antipsychotics versus clozapine in a monkey model: adverse effects and antiamphetamine effects. Psychopharmacology 144:189–197
Peacock L, Gerlach J (2001) Aberrant behavioral effects of a dopamine D1 receptor antagonist and agonist in monkeys: evidence of uncharted dopamine D1 receptor actions. Biol Psychiatry 50:501–509
Peacock L, Hansen L, Morkeberg F, Gerlach J (1999) Chronic dopamine D1, dopamine D2 and combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys: antiamphetamine effects and extrapyramidal side effects. Neuropsychopharmacology 20:35–43
Randrup A, Munkvad I, Fog R (1980) Mental and behavioral stereotypies elicited by stimulant drugs: relation to the dopamine hypothesis of schizophrenia, mania, and depression. Abstracts of the 12th Congress of Collegium Internationale Neuro-Psychopharmacologicum, Gothenburg, Sweden, 22–26 June 1980. Pergamon Press, New York
Snyder DM (1991) An alternative view of schizophrenic cognition. Speculations Sci Technol 14:211–217
Svensson A, Carlsson ML, Carlsson A (1992) Interaction between glutamatergic and dopaminergic tone in the nucleus accumbens of mice: evidence for a dual glutamatergic function with respect to motor control. J Neural Transm 88:235–240
Svensson A, Carlsson ML, Carlsson A (1994) Glutamatergic neurons projecting to the nucleus accumbens can affect motor functions in opposite directions depending on the dopaminergic tone. Prog Neuropsychopharmacol Biol Psychiatry 18:1203–1218
Szeszko PR, Bilder RM, Dunlop JA, Walder DJ, Lieberman JA (1999) Longitudinal assessment of methylphenidate effects on oral word production and symptoms in first-episode schizophrenia at acute and stabilized phases. Biol Psychiatry 45:680–686
Acknowledgements
The excellent technical assistance of Amanda Whitehead and Tearani Galbreath is gratefully acknowledged. We are also indebted to Nancy Lyon for permission to use the original database for this THEME analysis and for valuable discussions regarding this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lyon, M., Kemp, A.S. Increased temporal patterns in choice responding and altered cognitive processes in schizophrenia and mania. Psychopharmacology 172, 211–219 (2004). https://doi.org/10.1007/s00213-003-1646-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-003-1646-0